// App-Quantinova.ai

13853 : Biological Action of ABCA1 Ligand Peptide ATI-5261 and its Analogs With Improved Safety Features

Researchers

Presenter

  • Stefanie Bittner

Principal Investigators

  • Juveria Tabassum

  • Anouar Hafiane

  • Jacques Genest

  • Salman Azhar

  • Jan Johansson

Medical Centers

  • Medicine, VA Palo Alto HealthCare System and Stanford University, Palo Alto, CA

  • McGill Univ, Quebec, QC

  • Artery Therapeutics, San Ramon, CA

  • McGill Univ, Quebec, QC, Canada

  • Lawrence Berkeley National Lab, Berkeley, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved